Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
about
Pixantrone can be activated by formaldehyde to generate a potent DNA adduct forming agentBolus and continuous infusion mitoxantrone in newly diagnosed adult acute lymphoblastic leukemia: results of two consecutive phase II clinical studies.Synthesis and Solid State Structure of Fluorous Probe Molecules for Fluorous Separation Applications.Functional drug screening assay reveals potential glioma therapeutics.Effects of mitoxantrone on action potential and membrane currents in isolated cardiac myocytes.A Personal History of Quadruplex-Small Molecule Targeting.The effect of mitoxantrone treatment in beagle dogs previously treated with minimally cardiotoxic doses of doxorubicin.High-field 1H and 31P NMR studies on the binding of the anticancer agent mitoxantrone to d[CpGpApTpCpG]2.Phase I study of the combination of losoxantrone and cyclophosphamide in patients with refractory solid tumours.Relationship between the pharmacological activity of antitumor drugs Ametantrone and mitoxantrone (Novatrone) and their ability to condense nucleic acids.Preclinical models in electrochemotherapy: the role of veterinary patients.Theoretical design of a bistetrapeptide derivative of mitoxantrone targeted towards the double-stranded hexanucleotide sequence d(GGCGCC)2.High field 1H-NMR analysis of the 1:1 intercalation complex of the antitumor agent mitoxantrone and the DNA duplex [d(CpGpCpG)]Mitoxantrone, More than Just Another Topoisomerase II Poison.Anthraquinones As Pharmacological Tools and Drugs.Total synthesis, cytotoxic effects of damnacanthal, nordamnacanthal and related anthraquinone analogues.Site-specific and photo-induced alkylation of DNA by a dimethylanthraquinone-oligodeoxynucleotide conjugate.Pharmacokinetics of mitoxantrone in man and laboratory animals.Generation of nucleic acid structures and binding of molecules to DNA.Design of anticancer drugs using modeling techniques.Electron microscopic observations of the effects of anthraquinone derivatives on plasmid DNA.Encapsulation of Mitoxantrone within Cucurbit[8]uril Decreases Toxicity and Enhances Survival in a Mouse Model of Cancer.Photosensitization of anticancer agents--8. One-electron reduction of mitoxantrone: an EPR and spectrophotometric study.Dual inhibition of topoisomerases I and IIα by ruthenium(II) complexes containing asymmetric tridentate ligands.Binding mechanism of anti-cancer chemotherapeutic drug mitoxantrone to DNA characterized by magnetic tweezers.Validated Assay for the Determination of Mitoxantrone in Pharmaceuticals Using Capillary Zone Electrophoresis
P2860
Q24671854-E3DD0809-093E-4FE6-9B7F-877E6CB74942Q33503137-7226FBC2-7C46-4188-B383-ECDE0686EF2AQ33735223-164B10A2-1CF5-475A-86B4-840CE1D42580Q33780121-AB848AE5-D35D-41A1-BDE2-A701967E971CQ35028826-C323EA14-E0AD-4625-AED5-76A3A9E9E435Q35670057-EA5132B4-840D-4054-AC72-B8EB2FB4D741Q35856510-382D54AE-5A0F-4D4B-A47F-FA206457DC55Q36444345-BC93F632-2DBF-4CBC-987E-DBBB7B39018BQ36644062-5FFE4585-5C92-44AD-870C-6C57690BBDDAQ37396644-6AB85F93-BE49-454C-BF23-2C355C2016D0Q38029365-EC3D36A3-7C23-431E-9105-2C0016501DD0Q38336702-BF91CDD4-5512-4A50-B43D-BFB8E8E5E01EQ38352410-31AB2156-A6AF-471C-9AA5-856114890085Q38569206-58BC035E-8726-4FFD-9E83-7F90E49CECAAQ38816745-DE138402-C5C4-4040-A899-EC848E0F65ACQ39107017-616C7D91-4D69-4188-992B-458F76CA9E2BQ39717867-F826F1F0-90C9-41C5-A3D1-D7E8EEEC8698Q39764334-BC3D9A29-D9D7-4295-A71F-4BA87C58FE6CQ39821797-22386230-7D9D-40E7-AECF-154BF763A920Q41483253-CCB135F4-9AFC-4AB0-9663-51234A0C3928Q44362359-6CCD8D21-8A4A-4B31-A5F9-D58D82BC95F2Q47839279-CB83CBB4-4001-4954-95A7-DE6AAFE901D5Q50886298-9127D9B5-330D-4E68-9DD0-2DD9E1417214Q53414064-A2E8E051-5599-495D-89B0-F2C032E07574Q55633988-1183E288-4D59-4A58-BE86-7A9BCC4FD1ABQ58256689-C1981EC0-D0E8-4CCD-AD65-C62A2FE9D209
P2860
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
description
1979 nî lūn-bûn
@nan
1979 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1979 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1979年の論文
@ja
1979年論文
@yue
1979年論文
@zh-hant
1979年論文
@zh-hk
1979年論文
@zh-mo
1979年論文
@zh-tw
1979年论文
@wuu
name
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@ast
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@en
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@nl
type
label
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@ast
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@en
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@nl
prefLabel
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@ast
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@en
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@nl
P2093
P356
P1476
Antitumor agents. 1. 1,4-Bis[(aminoalkyl)amino]-9,10-anthracenediones.
@en
P2093
Citarella RV
Murdock KC
Wallace RE
P304
P356
10.1021/JM00195A002
P407
P577
1979-09-01T00:00:00Z